ライフサイエンスコーパス: suicidal

1 orists are "normal" and argues that they are suicidal.

2 behavior in persons who were not known to be suicidal.

3 systems that support people presenting with suicidal acts and self-harm are particularly at risk of

4 within minutes in a process dependent on the suicidal amidase autolysin LytA.

5 specific elements of suicide risk including suicidal and death-related thoughts, hopelessness, restl

6 biographical examination of perpetrators of suicidal attacks serves to alert us on the role played b

7 We documented one case of suicidal attempt in a woman following HIV seroconversion

8 , hemorrhage) and psychiatric complications (suicidal attenuation, hypomania) as well as high costs.

9 ted hazard ratio=1.04, 95% CI=0.96, 1.12) or suicidal behavior (adjusted hazard ratio=0.85, 95% CI=0.

10 ) months and greater lethality of subsequent suicidal behavior (b = 0.08; t = 2.89; P = .01).

11 isits were used to predict future documented suicidal behavior (i.e., suicide attempt or death).

12 hypothalamic-pituitary-adrenal (HPA) axis to suicidal behavior and its risk factors, such as depressi

13 zophrenia, the biomarkers also validated for suicidal behavior are enriched for genes involved in neu

14 ted higher suicidal ideation and more lethal suicidal behavior during a 2-year period.

15 lp better identify subjects at high risk for suicidal behavior for targeted prevention and interventi

16 Suicidal behavior has increased since the onset of the g

17 We aimed to quantify the risk of suicidal behavior in a large nationwide cohort of patien

18 mpaired decision making to increase risk for suicidal behavior in MDD.

19 ng the underlying mechanisms for the risk of suicidal behavior in patients with attention-deficit/hyp

20 rare cases may lead to suicidal ideation or suicidal behavior in persons who were not known to be su

21 es, yet little is known about the drivers of suicidal behavior in poor populations.

22 Predictors of suicidal behavior in the TD/CTD cohort were studied usin

23 risk and protective factors associated with suicidal behavior in this group.

24 Here we tested the hypothesis that suicidal behavior is associated with heightened aversion

25 Suicidal behavior is complex and manifests because of a

26 Suicidal behavior is often conceptualized as a response

27 d Bonferroni correction after validation for suicidal behavior map to biological pathways involved in

28 tion, and abuse affect the mental health and suicidal behavior of trafficked children.

29 Suicidal behavior should be monitored in these patients,

30 ar disorder is associated with high risk for suicidal behavior that often develops in adolescence and

31 Next, we validated for suicidal behavior the top-ranked biomarkers for SI, in a

32 ICD-9-based case definition for suicidal behavior was derived by expert clinician consen

33 Risk of suicidal behavior was estimated using conditional logist

34 hiatric hospital contacts due to depression, suicidal behavior, and all-cause mortality.

35 Importance: Biomarkers that predict suicidal behavior, especially highly lethal behavior, ar

36 rom the prioritization step for relevance to suicidal behavior, in a demographically matched cohort o

37 volving evidence that lithium use may reduce suicidal behavior, in addition to concerns that the use

38 ollowed up for 2 years with documentation of suicidal behavior, its lethality, and suicidal ideation

39 am and downstream factors in the etiology of suicidal behavior, within the contextual framework of in

40 sion models were used to study predictors of suicidal behavior.

41 so suggests that inflammation is involved in suicidal behavior.

42 ch has been linked to the pathophysiology of suicidal behavior.

43 be used to predict patients' future risk of suicidal behavior.

44 role in the pathophysiological mechanisms of suicidal behavior.

45 the development of psychiatric disorders and suicidal behavior.

46 in signaling in suicide and higher-lethality suicidal behavior.

47 al approaches to comorbidity in the study of suicidal behavior.

48 e conditions should be closely monitored for suicidal behavior.

49 g may attenuate the familial transmission of suicidal behavior.

50 en associated with psychiatric disorders and suicidal behavior.

51 ing and after the ED visit decreased post-ED suicidal behavior.

52 can be useful for predicting future risk of suicidal behavior.

53 ED-initiated intervention reduces subsequent suicidal behavior.

54 ic disorders, including problem gambling and suicidal behavior.

55 e on average) prediction of patients' future suicidal behavior.

56 alternative to lithium, are inconsistent for suicidal behavior.

57 at collectively showed the complex nature of suicidal behavior.

58 1.2% (N=20,246) met the case definition for suicidal behavior.

59 disrupting cellular pathways associated with suicidal behavior.

60 ding schizophrenia and psychotic illness and suicidal behavior.

61 ndent of depressed mood, for the most severe suicidal behaviors and may warrant inclusion in suicide

62 , a treatable risk factor, strongly predicts suicidal behaviors is cause for hope.

63 redictors of the emergence of depressive and suicidal behaviors throughout life.

64 an arterial input function; the severity of suicidal behaviors, including lethality and intent of su

65 incidence rate ratio, 2.0; 95% CI, 1.9-2.2), suicidal behaviors, mortality, and municipal support.

66 ch are strongly associated with self-harm or suicidal behaviors.

67 l illness onset, treatment non-response, and suicidal behaviors.

68 < 0.001), and lower likelihood of reporting suicidal behaviour (aPR = 0.71; 95% CI 0.51, 1.01; p = 0

69 cted on primary outcomes of interest, namely suicidal behaviour (suicide, attempt, or ideation), and

70 Suicidal behaviour differs between sexes, age groups, ge

71 dren and young people and a possible rise in suicidal behaviour in this group.

72 ntions that address symptoms associated with suicidal behaviour only (eg, hopelessness, depression, a

73 ect on Patient Health Questionnaire 9 score, suicidal behaviour, percentage of days of heavy drinking

74 tal health services is key to prevent future suicidal behaviour.

75 been implicated in psychiatric disorders and suicidal behaviour.

76 negative life events are key contributors to suicidal behaviour.

77 ta signalling pathway in the pathogenesis of suicidal behaviour.

78 tments of mental disorders can often prevent suicidal behaviour; additionally, regular follow-up of p

79 everal independent markers and predictors of suicidal behaviours converging to this increased risk.

80 Suicidal behaviours in adolescents are a major public he

81 of school-based preventive interventions of suicidal behaviours.

82 to be offset with the effectiveness and anti-suicidal benefits of lithium and the potential metabolic

83 have claimed that suicide terrorists are not suicidal, but rather psychologically normal individuals

84 Lankford claims that suicide terrorists are suicidal, but that their suicidal tendencies are often f

85 throcytes confers partial protection against suicidal cell death.

86 rum from patients with liver disease induced suicidal death of erythrocytes in relation to their plas

87 Bilirubin stimulated suicidal death of human erythrocytes.

88 The anti-suicidal effects of clozapine and lithium have been subs

89 In analogy to apoptosis of nucleated cells, suicidal erythrocyte death called eryptosis is character

90 Bilirubin triggers suicidal erythrocyte death, thus contributing to anemia

91 -1 to AP site-containing DNA appears to be a suicidal event when BER is overwhelmed or disrupted.

92 ty, and these cytokines may help distinguish suicidal from nonsuicidal patients.

93 The use of grafts from suicidal hanging donors (without hemodynamic instability

94 , 874-1467) and among patients admitted with suicidal ideas or behaviors (2078; 95% CI, 1512-2856).

95 Patients admitted because of suicidal ideas or behaviors and those in the first month

96 s had self-harmed and 35 (27%) had expressed suicidal ideas.

97 io [OR] 0.45, 95% CI 0.24-0.85; p=0.014) and suicidal ideation (0.5, 0.27-0.92; p=0.025).

98 0.45, 95% CI 0.24-0.85; p=0.014) and severe suicidal ideation (0.50, 0.27-0.92; p=0.025), compared w

99 rticipants), but not with treatment-emergent suicidal ideation (13 [21%] of 61 vs 19 [29%] of 65 part

100 patient), suicide attempt (4 patients), and suicidal ideation (2 patients).

101 MDD (odds ratio 1.98, 95% CI 1.11-3.53) and suicidal ideation (2.47, 1.19-5.10) compared with their

102 epression (AOR, 2.27; 95% CI, 1.22-4.23) and suicidal ideation (AOR, 3.43; 95% CI, 1.80-6.54).

103 anxiety (AOR, 2.13; 95% CI, 1.12-4.05), and suicidal ideation (AOR, 3.68; 95% CI, 1.77-7.67).

104 Inventory-II (BDI-II) and the Beck Scale for Suicidal Ideation (BSSI).

105 decreased biomarkers from the discovery for suicidal ideation (CADM1, CLIP4, DTNA, KIF2C), prioritiz

106 ly use and frequent use of cannabis and MDD, suicidal ideation (ever and persistent), and suicide pla

107 etwork was observed in patients with MDD and suicidal ideation (FDR-adjusted p < 0.05).

108 etween no suicidal ideation (no SI) and high suicidal ideation (high SI) states (n=12 participants ou

109 nt Health Questionnaire-9 was used to assess suicidal ideation (ie, "thoughts that you would be bette

110 f psychiatric participants for prediction of suicidal ideation (n=108), and in a future follow-up coh

111 y genes that change in expression between no suicidal ideation (no SI) and high suicidal ideation (hi

112 iences were more likely to report concurrent suicidal ideation (odds ratio [OR], 5.24; 95% CI, 2.85-9

113 me and depression were more likely to report suicidal ideation (p<0.0001) and suicide plans or attemp

114 ni biomarker list for predictive ability for suicidal ideation (SI) and for future hospitalizations f

115 e disorder and a score >/=4 on the Scale for Suicidal Ideation (SSI), of whom 54% (N=43) were taking

116 r Suicide, CFI-S), and how well they predict suicidal ideation across psychiatric diagnoses (AUC of 8

117 Indeed, the UP-Suicide was able to predict suicidal ideation across psychiatric diagnoses with an A

118 GRIK2 (which likely play a role in emergent suicidal ideation after antidepressant treatment), GRIK4

119 derstanding of the epidemiological impact of suicidal ideation after stroke is required to identify s

120 and early interventions to prevent and treat suicidal ideation after stroke, especially among subject

121 ram is associated with reduced likelihood of suicidal ideation among medical interns.

122 The pooled proportion of suicidal ideation among stroke survivors was 11.8% (7.4%

123 ysis was to estimate rates and correlates of suicidal ideation among stroke survivors.

124 onnectivity in 46 patients with MDD (23 with suicidal ideation and 23 without) and 36 age- and gender

125 activity subtypes of MDD patients had severe suicidal ideation and anhedonia symptoms.

126 nectivity may be associated with severity of suicidal ideation and attempt lethality.

127 Suicidal ideation and behavior currently have no quick-a

128 en right rostral prefrontal connectivity and suicidal ideation and between left ventral prefrontal co

129 sychotic or demented people, those with both suicidal ideation and clear intent, and those with subst

130 subjects, and had an increased prevalence of suicidal ideation and depressive symptoms.

131 y genes that change in expression between no suicidal ideation and high suicidal ideation states (n=3

132 he prefrontal regions, may favor more severe suicidal ideation and higher-lethality suicide attempts.

133 erotonin1A binding potential predicts future suicidal ideation and intent and lethality of future sui

134 ion of suicidal behavior, its lethality, and suicidal ideation and intent.

135 rotonin1A binding potential predicted higher suicidal ideation and more lethal suicidal behavior duri

136 Self-harm behaviors, including suicidal ideation and past suicide attempts, are frequen

137 Twelve-month suicidal ideation and suicide attempts.

138 This study focused on suicidal ideation and suicide attempts.

139 autistic traits, empathy, and likelihood of suicidal ideation and suicide plans or attempts.

140 n firing and release, which affects mood and suicidal ideation and thereby decision making.

141 e-duty military service members with current suicidal ideation and/or a recent suicide attempt.

142 Depression, anxiety, and suicidal ideation are more common among AD individuals,

143 ajor depressive disorder (MDD) patients with suicidal ideation are poorly understood.

144 lence of depression, depressive symptoms, or suicidal ideation as assessed by validated questionnaire

145 serotonin1A binding potential predicted more suicidal ideation at 3 (b = 0.02; t = 3.45; P = .001) an

146 analysis included only participants who had suicidal ideation at baseline (N=167).

147 ent resistance, 58 (12%) of 465 patients had suicidal ideation at screening, and 191 (60%) of 321 pat

148 Predefined outcomes were (1) rates of suicidal ideation based on random-effects pooled proport

149 nterns (12 of 100) assigned to wCBT endorsed suicidal ideation compared with 21.2% of interns (21 of

150 Cyberbullying was more strongly related to suicidal ideation compared with traditional bullying.

151 Symptoms of depression and suicidal ideation did not differ significantly between f

152 Rates of suicidal ideation diminished to a substantially greater

153 assigned to wCBT were less likely to endorse suicidal ideation during internship year (relative risk,

154 er attempted suicide or who had shown severe suicidal ideation during the 2 weeks before baseline.

155 o are most likely to experience remission of suicidal ideation following a course of MST.

156 psychotic experiences among individuals with suicidal ideation has potential clinical and public heal

157 Depression and suicidal ideation improved equally with both formats.

158 t to anecdotal reports of increased rates of suicidal ideation in adults with Asperger's syndrome, an

159 greater reduction in clinically significant suicidal ideation in depressed patients within 24 hours

160 Pharmacotherapy to rapidly relieve suicidal ideation in depression may reduce suicide risk.

161 ETATION: The increased likelihood of MDD and suicidal ideation in frequent cannabis users cannot be s

162 This study investigated specific changes of suicidal ideation in functional connectivity of MDD pati

163 Severity of suicidal ideation in MDD is related to brainstem and pre

164 eft orbitofrontal-both thalamic regions with suicidal ideation in MDD were inversely proportional to

165 lence of depression, depressive symptoms, or suicidal ideation in medical students published before S

166 ence of depression, depressive symptoms, and suicidal ideation in medical students.

167 travenous ketamine on clinically significant suicidal ideation in patients with major depressive diso

168 ng the number of suicide attempts and severe suicidal ideation in school-based adolescents.

169 buprenorphine was associated with decreased suicidal ideation in severely suicidal patients without

170 There were six cases of suicidal ideation in the group receiving pregabalin, thr

171 d 15 pupils (0.75%) reported incident severe suicidal ideation in the YAM group versus 31 (1.37%) in

172 In a subgroup analyses, the prevalence of suicidal ideation in those with both eczema and itch was

173 ysicians are at particularly high risk, with suicidal ideation increasing more than 4-fold during the

174 the substantial correlation between NSSI and suicidal ideation is largely driven by overlapping genet

175 Suicidal ideation is often associated with TRD and contr

176 The biomarkers for suicidal ideation only are enriched for genes involved i

177 Suicidality was defined as suicidal ideation or attempted or completed suicide.

178 egimens; suicidality was defined as reported suicidal ideation or attempted or completed suicide.

179 and those with a current or past history of suicidal ideation or behaviour (1.8% [18.78], t51=0.68;

180 d patients with a current or past history of suicidal ideation or behaviour.

181 (HR, 2.96; 95% CI, 1.24-7.08; P = .01), any suicidal ideation or gesture (HR, 2.44; 95% CI, 1.28-4.6

182 parasomnias, which in rare cases may lead to suicidal ideation or suicidal behavior in persons who we

183 relationship between peer victimization and suicidal ideation or suicide attempt in children or adol

184 relationship between peer victimization and suicidal ideation or suicide attempts using meta-analysi

185 Suicidal ideation prevalence data were extracted from 24

186 The prevalence of suicidal ideation ranged from 1102 (24.9%) of 4432 peopl

187 Ketamine's effect on suicidal ideation remained significant after adjusting f

188 Ketamine rapidly (within 1 day) reduced suicidal ideation significantly on both the clinician-ad

189 ession between no suicidal ideation and high suicidal ideation states (n=37 participants out of a coh

190 The overall pooled crude prevalence of suicidal ideation was 11.1% (2043/21002 individuals; 95%

191 among medical students was 27.2% and that of suicidal ideation was 11.1%.

192 Suicidal ideation was evaluated before initiation and af

193 Moreover, suicidal ideation was less likely in stroke survivors wh

194 Suicidal ideation was reported by 12.7% of all patients

195 across psychiatric diagnoses for predicting suicidal ideation was SLC4A4, with a receiver operating

196 Ketamine's effects on suicidal ideation were partially independent of its effe

197 motor cortex-were indicators of remission of suicidal ideation with 89% accuracy, 90% sensitivity, an

198 lar disorder in particular, SLC4A4 predicted suicidal ideation with an AUC of 93%, and future hospita

199 For bipolar disorder, it predicted suicidal ideation with an AUC of 98%, and future hospita

200 Inclusion criteria were the presence of suicidal ideation with intent to die during the past wee

201 who either attempted suicide or experienced suicidal ideation with intent, were randomly assigned to

202 association between depression, anxiety, and suicidal ideation with various dermatological diagnoses.

203 d a statistically nonsignificant increase in suicidal ideation with venlafaxine.

204 243 (66%) of 367 respondents self-reported suicidal ideation, 127 (35%) of 365 respondents self-rep

205 compare prevalences of depression, anxiety, suicidal ideation, and anxiety attacks, in adults with a

206 ondary outcomes of depression, hopelessness, suicidal ideation, and problem solving.

207 The primary outcome measure was change in suicidal ideation, as assessed by the Beck Suicide Ideat

208 ve previously shown to increase the risk for suicidal ideation, interns assigned to wCBT were less li

209 e-based study to explore the relationship of suicidal ideation, mental health problems, and social fu

210 ls with depression, and its association with suicidal ideation, needs further clarification.

211 ion, posttraumatic stress disorder, anxiety, suicidal ideation, self-injury, and suicide attempts.

212 sures were associated with increased odds of suicidal ideation, suicide plans, and suicide attempts i

213 Among respondents with suicidal ideation, those with psychotic experiences were

214 relationship between peer victimization and suicidal ideation, with a total of 284,375 participants.

215 about one out of eight stroke survivors has suicidal ideation.

216 the effects of a single dose of ketamine on suicidal ideation.

217 been studied in patients with low levels of suicidal ideation.

218 information integration in MDD patients with suicidal ideation.

219 students are at high risk for depression and suicidal ideation.

220 phine as a time-limited treatment for severe suicidal ideation.

221 include data on suicide, suicide attempt, or suicidal ideation.

222 d 191 (60%) of 321 patients had a history of suicidal ideation.

223 ) BPF, suggesting a role for both regions in suicidal ideation.

224 at risk for attempts among respondents with suicidal ideation.

225 antly negatively correlated with severity of suicidal ideation.

226 associations were found in individuals with suicidal ideation.

227 ethality and intent of suicide attempts; and suicidal ideation.

228 among individuals with a lifetime history of suicidal ideation.

229 h psoriasis had significant association with suicidal ideation.

230 ies included women with severe depression or suicidal ideation.

231 hat hypnotic medications are associated with suicidal ideation.

232 mate, suggesting a possible association with suicidal ideation.

233 for up to 1 week in depressed patients with suicidal ideation.

234 (SMD=-0.22; p=0.03) were all associated with suicidal ideation.

235 rm that ketamine exerts a specific effect on suicidal ideation.

236 nce of depression or depressive symptoms and suicidal ideation; and whether students who screened pos

237 aphic information, negative life events, and suicidal ideation; depression and anxiety were assessed

238 review to understand the association between suicidal ideations and behaviours and economic poverty i

239 uded studies testing the association between suicidal ideations and behaviours and economic poverty i

240 orting on the relationship between non-fatal suicidal ideations and behaviours and poverty, 36 associ

241 wealth, and unemployment is associated with suicidal ideations and behaviours.

242 arities between suicide terrorists and other suicidal individuals, Lankford also notes differences in

243 duce access to already purchased firearms by suicidal individuals.

244 T) is an empirically supported treatment for suicidal individuals.

245 eater lethality of past suicide attempts and suicidal intent and ideation.

246 Contrary to our hypotheses, suicidal intent was not predicted by serotonin1A binding

247 ate destruction of one's body tissue without suicidal intent, is a significant issue for many youth.

248 atients with bipolar disorder with suspected suicidal intentions, although risk for suicide is only o

249 However, what differentiates suicidal killers from those who "only" commit suicide?

250 re we show that miropin uses the serpin-type suicidal mechanism.

251 uicidality and are known targets of the anti-suicidal mood stabilizer drug lithium, which increases t

252 Neutrophil extracellular traps expelled from suicidal neutrophils comprise a complex structure of nuc

253 ated behavior (SRB) but never attempted, non-suicidal offspring, and a healthy control group.

254 hts of suicide, as individuals who are truly suicidal often do not share that information with clinic

255 were alcohol or drug dependent, were acutely suicidal or had attempted suicide in the previous 2 mont

256 Exclusion criteria consisted of suicidal or homicidal intent or psychosis.

257 Severely suicidal patients without substance abuse were randomly

258 with decreased suicidal ideation in severely suicidal patients without substance abuse.

259 ent for anxiety or depression, presence of a suicidal plan, bipolar disorder, psychosis, posttraumati

260 to ask is why individuals choose one form of suicidal protest over others.

261 The prevalence of increased suicidal risk (defined as moderate to high risk suicidal

262 episode (current and lifetime), past 30-day suicidal risk (no/low risk vs moderate/high risk), past

263 er gene and their association with increased suicidal risk among human immunodeficiency virus (HIV)-p

264 R/rs25531 locus is associated with increased suicidal risk among Ugandan PLWHA.

265 PR was found to be associated with increased suicidal risk before Bonferroni correction (p-value = 0.

266 een implicated in the aetiology of increased suicidal risk in non-HIV infected study populations and

267 intervention strategies aimed to reduce the suicidal risk in this group are warranted.

268 Increased suicidal risk is a predictor of future attempted and com

269 A protective effect on increased suicidal risk was found for the 5-HTTLPR/rs25531 S A all

270 erse events were reported, all of which were suicidal risks detected during screening.

271 ildhood maltreatment was associated with non-suicidal self-injury (odds ratio 3.42, 95% CI 2.74-4.26)

272 ials, and trials that reported events of non-suicidal self-injury as suicide attempts.

273 pes, we found stronger associations with non-suicidal self-injury in non-clinical samples.

274 Non-suicidal self-injury is being increasingly recognised as

275 ing of childhood maltreatment history in non-suicidal self-injury risk assessments might hold particu

276 l abuse and neglect) in association with non-suicidal self-injury.

277 ent and its subtypes are associated with non-suicidal self-injury.

278 ng its specific subtypes, in relation to non-suicidal self-injury.

279 tween subjects who go on to attempt suicide, suicidal subjects who never attempted suicide, and non-s

280 ubjects who never attempted suicide, and non-suicidal subjects with psychiatric disorders.

281 cide terrorists are suicidal, but that their suicidal tendencies are often frustrated by injunctive s

282 ive argument that suicide bombers are indeed suicidal, the next question to ask is why individuals ch

283 TSPO was not elevated in patients without suicidal thinking but was significantly increased in tho

284 s with general information about depression, suicidal thinking, and local mental health professionals

285 Rapid reduction in suicidal thoughts after ketamine treatment has mostly be

286 have been made to prevent the escalation of suicidal thoughts among training physicians.

287 avioural interventions that directly address suicidal thoughts and behaviour are effective immediatel

288 l and behavioural interventions that address suicidal thoughts and behaviour during treatment (direct

289 ns between aspects of cannabis use, MDD, and suicidal thoughts and behaviours and examine whether suc

290 Most people struggling with suicidal thoughts and behaviours do not receive treatmen

291 h patients at risk of suicide should address suicidal thoughts and behaviours with the patient direct

292 psychological science about the emergence of suicidal thoughts and behaviours, and emphasise the cent

293 f major depressive disorder (MDD) as well as suicidal thoughts and behaviours.

294 ut was significantly increased in those with suicidal thoughts compared with those without, most robu

295 activation (2.17 [1.34-3.00]; p<0.0001), and suicidal thoughts or attempts (0.61 [0.45-0.83]; p=0.001

296 days unable to work, behavioural activation, suicidal thoughts or attempts, intimate partner violence

297 ly, mice will never have guilty ruminations, suicidal thoughts, or rapid speech.

298 Ketamine rapidly reduced suicidal thoughts, within 1 day and for up to 1 week in

299 ailability between patients with and without suicidal thoughts.

300 searched, crossing the terms "suicide" and "suicidal" with each of the modern FDA-approved hypnotics